Candriam S.C.A.Candriam S.C.A.

Institutional investor · Portfolio as of Q3 2020

Top Holdings803 positions

Checking export access…
Activity:

Microsoft Corp.

2M$428.3M4.0%$117.42+70.35%
7 qtrssince 2019-Q1
Decreased
0

Amgen Inc.

1.3M$320.8M3.0%$169.93+24.37%
7 qtrssince 2019-Q1
Increased
77

Alphabet Inc.

173,195$253.8M2.4%$60.38+20.23%
7 qtrssince 2019-Q1
Increased
58

Amazon.com, Inc.

77,492$244M2.3%$89.54+75.83%
7 qtrssince 2019-Q1
Decreased
0

Merck & Co., Inc

2.9M$243.4M2.3%$63.36+3.62%
7 qtrssince 2019-Q1
Increased
71

Apple Inc.

2M$232M2.2%$46.11+143.39%
7 qtrssince 2019-Q1
Increased
85

REGENERON PHARMACEUTICALS

323,036$180.8M1.7%$437.45+26.77%
7 qtrssince 2019-Q1
Increased
64

Danaher Corporation

762,942$164.3M1.5%$147.98+25.35%
7 qtrssince 2019-Q1
Increased
60

Thermo Fisher Scientific Inc

349,238$154.2M1.4%$344.97+25.91%
7 qtrssince 2019-Q1
Increased
61

Vertex Pharmaceuticals Incorporated

558,131$151.9M1.4%$185.67+46.56%
7 qtrssince 2019-Q1
Increased
49

Meta Platforms Inc

546,410$143.1M1.3%$174.52+48.64%
7 qtrssince 2019-Q1
Decreased
0

The Procter & Gamble Co.

985,926$137M1.3%$92.21+29.39%
7 qtrssince 2019-Q1
Increased
54
BABABABA
ADR

ALIBABA GROUP HLDG LTD

449,711$132.2M1.2%$199.54+38.64%
7 qtrssince 2019-Q1
Increased
62

GILEAD SCIENCES INC

1.9M$121.7M1.1%$49.39+2.57%
7 qtrssince 2019-Q1
Increased
54

PAYPAL HLDGS INC

534,237$105.3M1.0%$115.34+68.95%
7 qtrssince 2019-Q1
Decreased
0

BIOGEN INC

367,589$104.3M1.0%$239.81+18.29%
7 qtrssince 2019-Q1
Increased
46

BRISTOL-MYERS SQUIBB CO

1.7M$102.2M1.0%$37.19+28.13%
7 qtrssince 2019-Q1
Increased
48
517,099$101.2M1.0%——
7 qtrssince 2019-Q1
Increased
54

ILLUMINA INC

297,582$92M0.9%$303.95-1.08%
7 qtrssince 2019-Q1
Increased
61

QUALCOMM INC

660,407$77.7M0.7%$82.71+25.25%
7 qtrssince 2019-Q1
Increased
63
$10.6B
AUM
803
Positions
Q3 2020
Filing
HI score · 2.5/5
Quarterly 13F Value Change
+2%Q2'19$8B-6%Q3'19$7.5B+24%Q4'19$9.3B-3%Q1'20$9B+5%Q2'20$9.5B+12%Q3'20$10.6B
Activity profile
$ moved · Q3'20
New11%Increased55%Decreased27%Exited7%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.2 years
<1Q6%1-4Q14%1-2Y80%2Y+0%

Candriam S.C.A. manages $10.6B across 803 positions as of Q3 2020. Top holdings: MSFT (4.0%), AMGN (3.0%), GOOGL (2.4%). Fund DNA: Steady Compounder. HoldingsIntel Score: 2.5/5.0.

Q3 2020 Summary

Active quarter - 57 new positions, 55 exits, 286 increased. Top move: AAPL (INCREASED, conviction 85). Portfolio: $10.6B across 803 positions.

Top holdings by portfolio weight

Total AUM$11B
MSFT4.02%
AMGN3.01%
GOOGL2.38%
AMZN2.29%
MRK2.29%
AAPL2.18%
REGN1.70%
DHR1.54%
TMO1.45%
VRTX1.43%
Other1.34%

Portfolio allocation by GICS sector

Sectors11
Healthcare30.74%
Technology19.21%
Unknown10.87%
Consumer Cyclical9.59%
Communication Services7.66%
Financial Services7.17%
Industrials5.19%
Consumer Defensive4.44%
Basic Materials1.90%
Real Estate1.31%
Other1.91%

Behavioral investing profile

Checking access…
Steady Compounder- primarily Healthcare, Technology, Unknown
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Solid(2.5 / 5.0)
Holdings P&L59
Conviction42
Concentration49
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
7Q
AEMAEMAGNICO EAGLE MINES LTD
Q4 2024 → Q2 2026+365,880 shares+$57.5M
7Q
AMZNAMZNAMAZON COM INC
Q4 2024 → Q2 2026+784,807 shares+$280.6M
7Q
CCCITIGROUP INC
Q4 2024 → Q2 2026+275,487 shares+$52.3M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used